1. Home
  2. NCA vs HRTX Comparison

NCA vs HRTX Comparison

Compare NCA & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California Municipal Value Fund

NCA

Nuveen California Municipal Value Fund

N/A

Current Price

$8.89

Market Cap

296.6M

Sector

Finance

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$0.77

Market Cap

146.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NCA
HRTX
Founded
1987
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
296.6M
146.8M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
NCA
HRTX
Price
$8.89
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
65.1K
2.1M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
3.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$154,904,000.00
Revenue This Year
N/A
$15.28
Revenue Next Year
N/A
$20.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.36
52 Week Low
$8.22
$0.75
52 Week High
$9.80
$2.61

Technical Indicators

Market Signals
Indicator
NCA
HRTX
Relative Strength Index (RSI) 33.29 22.92
Support Level $8.45 N/A
Resistance Level $9.21 $1.41
Average True Range (ATR) 0.19 0.07
MACD -0.05 -0.01
Stochastic Oscillator 5.44 3.68

Price Performance

Historical Comparison
NCA
HRTX

About NCA Nuveen California Municipal Value Fund

Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: